Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Dec 02, 2024. (Total: 6432 publications)
   dataset
Filtered By:
Next
Records 1-30 (of 34 Records)
Query Trace: Fleming M[original query]
Effectiveness of bivalent mrna vaccines in preventing symptomatic SARS-CoV-2 infection-increasing community access to testing program, United States, January-September 2023
Ciesla AA , Mak J , Roper LE , Fleming-Dutra KE , Smith ZR , Wiegand RE , Britton A , Miller J , Link-Gelles R .
Influenza Other Respir Viruses 2024 18 (11) e70038 type
Interim effectiveness of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccines against COVID-19-associated hospitalization among adults aged ≥18 years with immunocompromising conditions - VISION Network, September 2023-February 2024
Link-Gelles R , Rowley EAK , DeSilva MB , Dascomb K , Irving SA , Klein NP , Grannis SJ , Ong TC , Weber ZA , Fleming-Dutra KE , McEvoy CE , Akinsete O , Bride D , Sheffield T , Naleway AL , Zerbo O , Fireman B , Hansen J , Goddard K , Dixon BE , Rogerson C , Fadel WF , Duszynski T , Rao S , Barron MA , Reese SE , Ball SW , Dunne MM , Natarajan K , Okwuazi E , Shah AB , Wiegand R , Tenforde MW , Payne AB .
MMWR Morb Mortal Wkly Rep 2024 73 (12) 271-276 type
Early estimates of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults - increasing community access to testing program, United States, September 2023-January 2024
Link-Gelles R , Ciesla AA , Mak J , Miller JD , Silk BJ , Lambrou AS , Paden CR , Shirk P , Britton A , Smith ZR , Fleming-Dutra KE .
MMWR Morb Mortal Wkly Rep 2024 73 (4) 77-83 type
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
Miotto P , Tessema B , Tagliani E , Chindelevitch L , Starks AM , Emerson C , Hanna D , Kim PS , Liwski R , Zignol M , Gilpin C , Niemann S , Denkinger CM , Fleming J , Warren RM , Crook D , Posey J , Gagneux S , Hoffner S , Rodrigues C , Comas I , Engelthaler DM , Murray M , Alland D , Rigouts L , Lange C , Dheda K , Hasan R , Ranganathan UDK , McNerney R , Ezewudo M , Cirillo DM , Schito M , Köser CU , Rodwell TC .
Eur Respir J 2017 50 (6)
Development of COVID-19 vaccine policy - United States, 2020-2023
Oliver SE , Wallace M , Twentyman E , Moulia DL , Godfrey M , Link-Gelles R , Meyer S , Fleming-Dutra KE , Hall E , Wolicki J , MacNeil J , Bell BP , Lee GM , Daley MF , Cohn A , Wharton M .
Vaccine 2023 type
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions
Link-Gelles R , Britton A , Fleming-Dutra KE .
Vaccine 2023
Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023
Plumb ID , Briggs Hagen M , Wiegand R , Dumyati G , Myers C , Harland KK , Krishnadasan A , James Gist J , Abedi G , Fleming-Dutra KE , Chea N , Lee JE , Kellogg M , Edmundson A , Britton A , Wilson LE , Lovett SA , Ocampo V , Markus TM , Smithline HA , Hou PC , Lee LC , Mower W , Rwamwejo F , Steele MT , Lim SC , Schrading WA , Chinnock B , Beiser DG , Faine B , Haran JP , Nandi U , Chipman AK , LoVecchio F , Eucker S , Femling J , Fuller M , Rothman RE , Curlin ME , Talan DA , Mohr NM .
Vaccine 2023 type
Pre-Delta, Delta, and Omicron periods of the coronavirus disease 2019 (COVID-19) pandemic and health outcomes during delivery hospitalization
Carlson J , Simeone RM , Ellington S , Galang R , DeSisto CL , Fleming-Dutra K , Riley L , Meaney-Delman D , Tong VT .
Obstet Gynecol 2023 143 (1) 131-138
Effectiveness of a messenger RNA vaccine booster dose against coronavirus disease 2019 among US healthcare personnel, October 2021-July 2022
Plumb ID , Mohr NM , Hagen M , Wiegand R , Dumyati G , Harland KK , Krishnadasan A , Gist JJ , Abedi G , Fleming-Dutra KE , Chea N , Lee J , Barter D , Brackney M , Fridkin SK , Wilson LE , Lovett SA , Ocampo V , Phipps EC , Marcus TM , Smithline HA , Hou PC , Lee LC , Moran GJ , Krebs E , Steele MT , Lim SC , Schrading WA , Chinnock B , Beiser DG , Faine B , Haran JP , Nandi U , Chipman AK , LoVecchio F , Talan DA , Pilishvili T .
Open Forum Infect Dis 2023 10 (10) ofad457 type
Effectiveness of monovalent and bivalent mRNA vaccines in preventing COVID-19-associated emergency department and urgent care encounters among children aged 6 months-5 years - VISION Network, United States, July 2022-June 2023
Link-Gelles R , Ciesla AA , Rowley EAK , Klein NP , Naleway AL , Payne AB , Kharbanda A , Natarajan K , DeSilva MB , Dascomb K , Irving SA , Zerbo O , Reese SE , Wiegand RE , Najdowski M , Ong TC , Rao S , Stockwell MS , Stephens A , Goddard K , Martinez YC , Weber ZA , Fireman B , Hansen J , Timbol J , Grannis SJ , Barron MA , Embi PJ , Ball SW , Gaglani M , Grisel N , Arndorfer J , Tenforde MW , Fleming-Dutra KE .
MMWR Morb Mortal Wkly Rep 2023 72 (33) 886-892
Interim recommendations for use of bivalent mRNA COVID-19 vaccines for persons aged 6 months - United States, April 2023
Moulia DL , Wallace M , Roper LE , Godfrey M , Rosenblum HG , Link-Gelles R , Britton A , Daley MF , Meyer S , Fleming-Dutra KE , Oliver SE , Twentyman E .
MMWR Morb Mortal Wkly Rep 2023 72 (24) 657-662
Effectiveness of booster doses of monovalent mRNA COVID-19 vaccine against symptomatic severe acute respiratory syndrome coronavirus 2 infection in children, adolescents, and adults during omicron subvariant BA.2/BA.2.12.1 and BA.4/BA.5 predominant periods
Ciesla AA , Wiegand RE , Smith ZR , Britton A , Fleming-Dutra KE , Miller J , Accorsi EK , Verani JR , Shang N , Derado G , Pilishvili T , Link-Gelles R .
Open Forum Infect Dis 2023 10 (5) ofad187
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
Allix-Béguec C , Arandjelovic I , Bi L , Beckert P , Bonnet M , Bradley P , Cabibbe AM , Cancino-Muñoz I , Caulfield MJ , Chaiprasert A , Cirillo DM , Clifton DA , Comas I , Crook DW , De Filippo MR , de Neeling H , Diel R , Drobniewski FA , Faksri K , Farhat MR , Fleming J , Fowler P , Fowler TA , Gao Q , Gardy J , Gascoyne-Binzi D , Gibertoni-Cruz AL , Gil-Brusola A , Golubchik T , Gonzalo X , Grandjean L , He G , Guthrie JL , Hoosdally S , Hunt M , Iqbal Z , Ismail N , Johnston J , Khanzada FM , Khor CC , Kohl TA , Kong C , Lipworth S , Liu Q , Maphalala G , Martinez E , Mathys V , Merker M , Miotto P , Mistry N , Moore DAJ , Murray M , Niemann S , Omar SV , Ong RT , Peto TEA , Posey JE , Prammananan T , Pym A , Rodrigues C , Rodrigues M , Rodwell T , Rossolini GM , Sánchez Padilla E , Schito M , Shen X , Shendure J , Sintchenko V , Sloutsky A , Smith EG , Snyder M , Soetaert K , Starks AM , Supply P , Suriyapol P , Tahseen S , Tang P , Teo YY , Thuong TNT , Thwaites G , Tortoli E , van Soolingen D , Walker AS , Walker TM , Wilcox M , Wilson DJ , Wyllie D , Yang Y , Zhang H , Zhao Y , Zhu B .
N Engl J Med 2018 379 (15) 1403-1415
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Klein NP , Demarco M , Fleming-Dutra KE , Stockwell MS , Kharbanda AB , Gaglani M , Rao S , Lewis N , Irving SA , Hartmann E , Natarajan K , Dalton AF , Zerbo O , DeSilva MB , Konatham D , Stenehjem E , Rowley EAK , Ong TC , Grannis SJ , Sloan-Aagard C , Han J , Verani JR , Raiyani C , Dascomb K , Reese SE , Barron MA , Fadel WF , Naleway AL , Nanez J , Dickerson M , Goddard K , Murthy K , Grisel N , Weber ZA , Dixon BE , Patel P , Fireman B , Arndorfer J , Valvi NR , Griggs EP , Hallowell C , Embi PJ , Ball SW , Thompson MG , Tenforde MW , Link-Gelles R .
Pediatrics 2023 151 (5) type
Evaluation of Correctional Facility COVID-19 Outbreaks With Layered Mitigation Strategies Including Vaccination: Colorado, 2020-2021.
Martinez HE , Marshall KE , Showell VW , Tate JE , Kirking HL , Broudy M , Matzinger SR , Burakoff A , Deng L , Payne DC , Fleming-Dutra K , Jervis RH .
J Correct Health Care 2023 29 (3) 198-205
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R , Ciesla AA , Roper LE , Scobie HM , Ali AR , Miller JD , Wiegand RE , Accorsi EK , Verani JR , Shang N , Derado G , Britton A , Smith ZR , Fleming-Dutra KE .
MMWR Morb Mortal Wkly Rep 2023 72 (5) 119-124 type
When to update COVID-19 vaccine composition.
Grant R , Sacks JA , Abraham P , Chunsuttiwat S , Cohen C , Figueroa JP , Fleming T , Fine P , Goldblatt D , Hasegawa H , MacIntrye CR , Memish ZA , Miller E , Nishioka S , Sall AA , Sow S , Tomori O , Wang Y , Van Kerkhove MD , Wambo MA , Cohen HA , Mesfin S , Otieno JR , Subissi L , Briand S , Wentworth DE , Subbarao K .
Nat Med 2023 29 (4) 776-780 type
Invasive Group A Streptococcal Penicillin Binding Protein 2× Variants Associated with Reduced Susceptibility to β-Lactam Antibiotics in the United States, 2015-2021.
Chochua S , Metcalf B , Li Z , Mathis S , Tran T , Rivers J , Fleming-Dutra KE , Li Y , McGee L , Beall B .
Antimicrob Agents Chemother 2022 66 (9) e0080222
Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
Moline HL , Keaton A , Rice W , Varghese J , Deng L , Waters A , Barringer A , Winston D , Fields V , Slifka KJ , Verani JR , Schrag SJ , Jernigan J , Tate JE , Fleming-Dutra KE .
Clin Infect Dis 2022 75 S155-S158 type
Continued Increase of Erythromycin- and Clindamycin-Nonsusceptibility among Invasive Group A Streptococci Driven by Genomic Clusters, USA, 2018-2019.
Li Y , Rivers J , Mathis S , Li Z , McGee L , Chochua S , Metcalf BJ , Fleming-Dutra KE , Nanduri SA , Beall B .
Clin Infect Dis 2022 76 (3) e1266-e1269 type
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
Fleming-Dutra KE , Britton A , Shang N , Derado G , Link-Gelles R , Accorsi EK , Smith ZR , Miller J , Verani JR , Schrag SJ .
JAMA 2022 327 (22) 2210-2219 type
Cluster Transmission Drives Invasive Group A Streptococcus Disease Within the US and is Focused on Communities Experiencing Disadvantage.
Metcalf B , Nanduri S , Chochua S , Li Y , Fleming-Dutra K , McGee L , Beall B .
J Infect Dis 2022 226 (3) 546-553 type
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
Britton A , Fleming-Dutra KE , Shang N , Smith ZR , Dorji T , Derado G , Accorsi EK , Ajani UA , Miller J , Schrag SJ , Verani JR .
JAMA 2022 327 (11) 1032-1041
A Veterans' Healthcare Administration (VHA) antibiotic stewardship intervention to improve outpatient antibiotic use for acute respiratory infections: A cost-effectiveness analysis.
Yoo M , Madaras-Kelly K , Nevers M , Fleming-Dutra KE , Hersh AL , Ying J , Haaland B , Samore M , Nelson RE .
Infect Control Hosp Epidemiol 2021 43 (10) 1-7
SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021.
Gettings JR , Gold JAW , Kimball A , Forsberg K , Scott C , Uehara A , Tong S , Hast M , Swanson MR , Morris E , Oraka E , Almendares O , Thomas ES , Mehari L , McCloud J , Roberts G , Crosby D , Balajee A , Burnett E , Chancey RJ , Cook P , Donadel M , Espinosa C , Evans ME , Fleming-Dutra KE , Forero C , Kukielka EA , Li Y , Marcet PL , Mitruka K , Nakayama JY , Nakazawa Y , O'Hegarty M , Pratt C , Rice ME , Rodriguez Stewart RM , Sabogal R , Sanchez E , Velasco-Villa A , Weng MK , Zhang J , Rivera G , Parrott T , Franklin R , Memark J , Drenzek C , Hall AJ , Kirking HL , Tate JE , Vallabhaneni S .
Clin Infect Dis 2021 74 (2) 319-326 type
Vaccination of contacts of Ebola virus disease survivors to prevent further transmission.
Doshi RH , Fleming M , Mukoka AK , Carter RJ , Hyde TB , Choi M , Nzaji MK , Bateyi SH , Christie A , Nichol ST , Damon IK , Beach M , Musenga EM , Fitter DL .
Lancet Glob Health 2020 8 (12) e1455-e1456 type
Incidence of pharyngitis, sinusitis, acute otitis media, and outpatient antibiotic prescribing preventable by vaccination against group A Streptococcus in the United States.
Lewnard JA , King LM , Fleming-Dutra KE , Link-Gelles R , Van Beneden CA .
Clin Infect Dis 2020 73 (1) e47-e58
Combining genomics and epidemiology to track mumps virus transmission in the United States.
Wohl S , Metsky HC , Schaffner SF , Piantadosi A , Burns M , Lewnard JA , Chak B , Krasilnikova LA , Siddle KJ , Matranga CB , Bankamp B , Hennigan S , Sabina B , Byrne EH , McNall RJ , Shah RR , Qu J , Park DJ , Gharib S , Fitzgerald S , Barreira P , Fleming S , Lett S , Rota PA , Madoff LC , Yozwiak NL , MacInnis BL , Smole S , Grad YH , Sabeti PC .
PLoS Biol 2020 18 (2) e3000611 type
A prolonged and large outbreak of invasive group A streptococcal disease within a nursing home: repeated intra-facility transmission of a single strain.
Nanduri SA , Metcalf BJ , Arwady MA , Edens C , Lavin MA , Morgan J , Clegg W , Beron A , Albertson JP , Link-Gelles R , Ogundimu A , Gold J , Jackson D , Chochua S , Stone N , Van Beneden C , Fleming-Dutra K , Beall B .
Clin Microbiol Infect 2018 25 (2) 248 e1-248 e7 type
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
Cohen MS , Chen YQ , McCauley M , Gamble T , Hosseinipour MC , Kumarasamy N , Hakim JG , Kumwenda J , Grinsztejn B , Pilotto JH , Godbole SV , Chariyalertsak S , Santos BR , Mayer KH , Hoffman IF , Eshleman SH , Piwowar-Manning E , Cottle L , Zhang XC , Makhema J , Mills LA , Panchia R , Faesen S , Eron J , Gallant J , Havlir D , Swindells S , Elharrar V , Burns D , Taha TE , Nielsen-Saines K , Celentano DD , Essex M , Hudelson SE , Redd AD , Fleming TR .
N Engl J Med 2016 375 (9) 830-9
TOP